San Francisco Sentry Investment Group CA trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL) by 68.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 703 shares of the company’s stock after selling 1,500 shares during the quarter. San Francisco Sentry Investment Group CA’s holdings in Colgate-Palmolive were worth $51,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Northern Trust Corp boosted its position in shares of Colgate-Palmolive by 1.4% in the first quarter. Northern Trust Corp now owns 10,906,808 shares of the company’s stock worth $747,553,000 after purchasing an additional 146,144 shares during the period. Geode Capital Management LLC boosted its position in shares of Colgate-Palmolive by 7.9% in the fourth quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock worth $626,200,000 after purchasing an additional 768,550 shares during the period. FIL Ltd boosted its position in shares of Colgate-Palmolive by 9.6% in the first quarter. FIL Ltd now owns 7,972,928 shares of the company’s stock worth $546,465,000 after purchasing an additional 695,987 shares during the period. FMR LLC boosted its position in shares of Colgate-Palmolive by 29.1% in the first quarter. FMR LLC now owns 7,384,604 shares of the company’s stock worth $506,141,000 after purchasing an additional 1,665,348 shares during the period. Finally, OppenheimerFunds Inc. boosted its position in shares of Colgate-Palmolive by 2.5% in the first quarter. OppenheimerFunds Inc. now owns 5,855,519 shares of the company’s stock worth $401,337,000 after purchasing an additional 142,293 shares during the period. Institutional investors own 75.83% of the company’s stock.
Colgate-Palmolive stock traded down $0.05 during mid-day trading on Friday, reaching $74.15. 2,474,438 shares of the company’s stock traded hands, compared to its average volume of 2,989,956. The company has a quick ratio of 0.78, a current ratio of 1.13 and a debt-to-equity ratio of 32.25. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $76.41. The company has a market cap of $63.66 billion, a price-to-earnings ratio of 24.97, a PEG ratio of 4.78 and a beta of 0.76. The stock has a 50 day moving average of $72.56 and a two-hundred day moving average of $70.38.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Thursday, July 18th were given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date of this dividend was Wednesday, July 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.91%.
A number of equities analysts have weighed in on CL shares. Citigroup upped their price target on shares of Colgate-Palmolive from $77.00 to $79.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 20th. Morgan Stanley boosted their target price on shares of Colgate-Palmolive from $72.00 to $74.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. UBS Group boosted their target price on shares of Colgate-Palmolive from $80.00 to $82.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $77.00 target price on the stock. in a report on Friday, June 7th. Finally, Argus boosted their target price on shares of Colgate-Palmolive from $72.00 to $82.00 and gave the stock a “buy” rating in a report on Tuesday, June 11th. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and six have issued a buy rating to the company. Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus target price of $73.87.
In other news, SVP John J. Huston sold 473 shares of the company’s stock in a transaction dated Monday, June 17th. The shares were sold at an average price of $72.93, for a total value of $34,495.89. Following the transaction, the senior vice president now directly owns 59,668 shares in the company, valued at $4,351,587.24. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Philip G. Shotts sold 8,919 shares of the company’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $71.05, for a total transaction of $633,694.95. Following the completion of the transaction, the vice president now owns 50,399 shares in the company, valued at $3,580,848.95. The disclosure for this sale can be found here. Insiders have sold 544,785 shares of company stock worth $39,166,850 in the last quarter. Company insiders own 1.14% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Article: How does the Beige Book influence monetary policy?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.